Progress of the chemical reactions was monitored by thin layer chromatography (TLC) and/or by Ultra Performance Liquid Chromatography—Mass Spectrometry (UPLC-MS). TLC was performed using Merck® commercial aluminium sheets coated with silica gel 60 F254. Visualization was achieved by fluorescence quenching under UV light at 254 nm, 215 nm or stained by potassium permanganate and bromocresol green. Purifications were performed by reversed-phase flash chromatography on prepacked columns (Macherey-Nagel® Chromabond) under pressure using a Combiflash® C18 Rf200 instrument and by preparative HPLC Buchi Pure C-380 on an OmniSphere C18 Dynamax (10 µm, 250 mm × 41.4 mm) column. Products were detected by UV absorption at 215 nm and 254 nm. UPLC-MS analysis was performed on LC-MS Waters ACQUITY UPLC I-Class system equipped with a UPLC I BIN SOL MGR solvent manager, a UPLC I SMP MGR-FTN sample manager, an ACQUITY UPLC I-Class eK PDA Detector photodiode array detector (210–400 nm) and an ACQUITY QDa (Performance) as mass detector (full scan ESI+/- in the range 30–1250). Acquity BEH C18 column (1.7 μm, 50 mm × 2.1 mm) was used for UPLC analysis. The injection volume was 0.5 μL. For a 5 min analysis, the elution was done at pH 3.8 from 100% H2O/0.1% ammonium formate to 2% H2O/98% ACN/0.1% ammonium formate over 3.5 min. A flow rate at 600 µL/min was used. For a 30 min analysis, the elution was done at pH 3.8 from 100% H2O/0.1% ammonium formate to 100% ACN/0.1% ammonium formate over 25 min. A flow rate at 600 µL/min was used. HRMS analysis were performed on a LCT Premier XE Micromass, using a Waters C18 X-Bridge (3.5 μm, 50 mm x 4.6 mm). A gradient starting from 98% H2O 5 mM ammonium formate pH = 3.8 and reaching 100% ACN 5 mM ammonium formate pH = 3.8 within 3 min at a flow rate of 1 mL/min was used.
4.6.1. Chemical Synthesis
4.6.1.1. General Procedure for the Synthesis of DHLc-Me-oxalate and Lc-Me-oxalate
In a 25 mL round bottom flask, 1 eq. of STL was dissolved either in dry ACN (for DHLc) or DMF (for Lc) (0.18 M). Then, 2 eq. of Et3N were added. After cooling to 0°C, a solution of methyl 2-chloro-2-oxo-acetate (1 eq.) in dry ACN or DMF (0.18 M) was added dropwise over 5 minutes under argon atmosphere. The mixture was stirred for 2 h at 0°C under argon. Then, 0.5 eq. of Et3N were added, followed by a solution of methyl 2-chloro-2-oxo-acetate (0.25 eq.) in dry ACN or DMF (0.18 M). After completion, the reaction mixture was evaporated under reduced pressure. The following purification by reversed-phase chromatography afforded the desired compounds.
DHLc-Me-oxalate was obtained as a white powder after purification by reversed-phase chromatography on a 15 g-cartridge, with a gradient from 90% of H2O to 30/70 of ACN/H2O (210 mg, 64% yield). 1H NMR (300 MHz, DMSO) δ 6.35 (d, J = 1.1 Hz, 1H, H-3), 5.42 (dd, J = 17.4, 1.6 Hz, 1H, H-15), 5.25 (d, J = 5.3 Hz, 1H, OH-8), 5.05 (d, J = 16.7 Hz, 1H, H-15’), 3.89–3.73 (m, 5H, H-5, H-6, H-18), 3.63–3.51 (m, 1H, H-8), 2.76–2.60 (m, 2H, H-11), 2.34 (s, 3H, H-14), 2.28 (dd, J = 13.6, 1.8 Hz, 1H, H-9), 2.20–2.08 (m, 1H, H-7), 1.26 (d, J = 7.0 Hz, 3H, H-13). 13C NMR (75 MHz, DMSO) δ 193.81 (Cq, C-2), 177.54 (Cq, C-12), 165.73 (Cq, C-4), 157.07 (Cq, C-17), 156.26 (Cq, C-16), 148.52 (Cq, C-10), 132.69 (CH, C-3), 131.17 (Cq, C-1), 80.07 (CH, C-6), 67.72 (CH, C-8), 64.83 (CH2, C-15), 59.84 (CH, C-7), 53.38 (CH3-C18), 48.34 (CH2, C-9), 48.11 (CH, C-5), 40.42 (CH, C-11), 21.18 (CH3, C-14), 15.17 (CH3, C-13).
Lc-Me-oxalate was obtained as a white powder after purification by reversed-phase flash chromatography on a 4 g-cartridge, with a gradient from 90% of H2O to 30/70 of ACN/H2O (53 mg, 80%). 1H NMR (300 MHz, DMSO) δ 6.37 (d, J = 1.3 Hz, 1H, H-3), 6.15 (dd, J = 3.0, 1.4 Hz, 1H, H-13), 6.04 (dd, J = 3.2, 1.4 Hz, 1H, H-13’), 5.51 (d, J = 5.4 Hz, 1H, OH-8), 5.43 (dd, J = 17.3, 1.6 Hz, 1H, H-15), 5.09 (d, J = 16.8 Hz, 1H, H-15’), 3.98 (d, J = 10.0 Hz, 1H, H-5), 3.87–3.70 (m, 5H, H-6, H-8, H-18), 3.16–3.06 (m, 1H, H-7), 2.78 (dd, J = 13.5, 10.7 Hz, 1H, H-9), 2.34 (s, 3H, H-14), 2.35–2.28 (m, 1H, H-9). 13C NMR (75 MHz, DMSO) δ 194.26 (Cq, C-2), 169.03 (Cq, C-12), 165.86 (Cq, C-4), 157.59 (Cq, C-17), 156.78 (Cq, C-16), 148.62 (Cq, C-10), 138.24 (Cq, C-11), 133.48 (CH, C-3), 131.94 (Cq, C-1), 122.25 (CH2, C-13), 80.88 (CH, C-6), 66.83 (CH, C-8), 65.30 (CH2, C-15), 56.63 (CH, C-7), 53.90 (CH3-C18), 48.92 (CH2, C-9), 48.58 (CH, C-5), 21.74 (CH3, C-14).
4.6.1.2. General Procedure for the Synthesis of DHLc-oxalate and Lc-oxalate
A 10 ml round bottom flask was charged with 1 eq. of STL-methyl-oxalate, 1:1 THF:H2O (1M) and a magnetic stir bar under ambient atmosphere. After cooling the biphasic mixture to 0°C, 1 eq. of LiOH (aq.) 0.5 M was added dropwise. The mixture was then vigorously stirred at 0°C for 10 minutes. The presence of the acid was confirmed by LC-MS and TLC staining with bromocresol green (blue spot). The crude was then extracted six times with ethyl acetate. The water layer was freeze-dried and the pure oxalates were obtained after purification by reversed-phase preparative HPLC.
DHLc-oxalate was obtained as a white powder after purification by reversed-phase preparative HPLC, with a gradient from 100% H2O (0.1% HCOOH) to 50% ACN (0.1% HCOOH) in 25 min (30mg, 21%). 1H NMR (300 MHz, DMSO) δ 6.27 (d, J = 1.2 Hz, 1H, H-3), 5.37 (dd, J = 5.4, 1.6 Hz, 1H, H-15), 5.23 (bs, 1H, OH-8), 5.02 (d, J = 17.3 Hz, 1H, H-15), 3.84 (d, J = 10.0 Hz, 1H, H-5), 3.80–3.75 (m, 1H, H-6), 3.60–3.54 (m, 1H, H-8), 2.72 (dd, J = 13.5, 10.9 Hz, 1H, H-9’), 2.68–2.62 (m, 1H, H-11), 2.34 (s, 3H, H-14), 2.27 (dd, J = 13.6, 1.8 Hz, 1H, H-9), 2.20–2.12 (m, 1H, H-7), 1.26 (d, J = 7.0 Hz, 3H, H-13). 13C NMR (75 MHz, DMSO) δ 194.28 (Cq, C-2), 178.06 (Cq, C-12), 166.61 (Cq, C-4), 159.27 (Cq, C-16/17), 149.04 (Cq, C-10), 133.04 (CH, C-3), 131.69 (Cq, C-1), 80.60 (CH, C-6), 68.25 (CH, C-8), 64.75 (CH2, C-15), 60.37 (CH, C-7), 48.86 (CH2, C-9), 48.66 (CH, C-5), 40.94 (CH, C-11), 21.70 (CH3, C-14), 15.70, (CH3, C-13). HRMS (TOF, ES+) m/z [M+H]+: calcd. for C17H18O8 351.1080, found 351.1074.
Lc-oxalate was obtained as a white powder after purification by reversed-phase preparative HPLC, with a gradient from 100% H2O (0.1% HCOOH) to 30% ACN (0.1% HCOOH) in 25 min (12.3 mg, 16%). 1H N(300 MHz, DMSO) δ 6.30 (s, 1H, H-3), 6.16 (d, J = 1.5 Hz, 1H, H-13), 6.04 (d, J = 1.8 Hz, 1H, H-13’), 5.53 (bs, 1H, OH-8), 5.37 (d, J = 17.1 Hz, 1H, H-15), 5.03 (d, J = 17.4 Hz, 1H, H-15’), 3.98 (d, J = 10.0 Hz, 1H, H-5), 3.85–3.80 (m, 1H, H-6), 3.78–3.73 (m, 1H, H-8), 3.16-3.09 (m, 1H, H-7), 2.79 (dd, J = 13.5, 10.7 Hz, 1H, H-9’), 2.36 (s, 3H, H-14), 2.33 (dd, J = 13.8, 1.8 Hz, 1H, H-9). 13C NMR (75 MHz, DMSO) δ 194.25 (Cq, C-2), 169.06 (Cq, C-12), 166.54 (Cq, C-4), 160.32 (Cq, C-17), 159.76 (Cq, C-16), 148.58 (Cq, C-10), 138.26 (Cq, C-11), 133.25 (CH, C-3), 131.96 (Cq, C-1), 122.23 (CH2, C-13), 80.90 (CH, C-6), 66.85 (CH, C-8), 64.33 (CH2, C-15), 56.66 (CH, C-7), 48.90 (CH2, C-9), 48.60 (CH, C-5), 21.75 (CH3, C-14). HRMS (TOF, ES+) m/z [M+H]+: calcd. for C17H16O8 349.0923, found 349.0918.